Douglas Tsao Stock Analyst Profile - HC Wainwright & Co. Research Coverage - Stocknear

Douglas Tsao

Stock Analyst at HC Wainwright & Co.

(3.7)
# 2452
Out of 5,470 analysts
637
Total ratings
Success rate
Average return
54 Stocks
Name Action PT Current % Upside Ratings Updated
RAPP Rapport Therapeutics
Maintains: Strong Buy
31 34
33.31 2.07% 2 Sep 8, 2025
IMVT Immunovant
Reiterates: Buy
35 35
16.46 112.64% 23 Sep 4, 2025
RZLT Rezolute
Reiterates: Buy
14 14
7.89 77.44% 18 Sep 3, 2025
OTLK Outlook Therapeutics
Downgrades: Neutral
1
0.95 5.26% 17 Aug 29, 2025
EVO Evotec
Maintains: Buy
8 7
3.5 100% 10 Aug 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
54 30
14.95 100.67% 15 Aug 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
27 20
7.69 160.08% 28 Aug 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
105 115
41.5 177.11% 25 Aug 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
720 774
763.41 1.39% 40 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
46 46
28.08 63.82% 24 Jul 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
118 118
62.69 88.23% 16 Jul 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
81 81
35.29 129.53% 24 Jun 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
18 18
13.02 38.25% 20 Jun 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
12 12
8.68 38.25% 23 Jun 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
25 25
1.69 1379.29% 26 Jun 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
80 80
55.67 43.7% 33 Jun 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
53 53
38.25 38.56% 5 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
1.38 407.25% 25 Apr 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
34 34
19.29 76.26% 16 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
19 19
17.23 10.27% 4 Apr 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
12 12
2.08 476.92% 17 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
18 18
5.58 222.58% 14 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
18 18
1.66 984.34% 7 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
57 57
27.23 109.33% 26 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
15 15
13.91 7.84% 15 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
5 5
2.22 125.23% 14 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
5 5
n/a n/a 10 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
2 2
0.55 263.64% 19 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
7 7
3.65 80.82% 19 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
360 360
0.74 48548.65% 8 Oct 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
41 45
44.96 0.09% 6 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
4 3
n/a n/a 2 Aug 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
6
5.11 17.42% 3 Mar 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Jan 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
74
116.3 -36.37% 1 Nov 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
10
1.09 817.43% 5 Jun 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
48 30
n/a n/a 2 Mar 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
5
n/a n/a 1 Dec 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
23 10
30 -66.67% 7 Dec 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
162 220
n/a n/a 5 Feb 4, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
14 14
n/a n/a 6 Oct 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
53
n/a n/a 9 Aug 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
11 10
n/a n/a 7 Aug 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
168 182
177.34 2.63% 4 Feb 20, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
19
7 167.86% 2 Jan 23, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
25 18
39.63 -54.58% 3 Aug 29, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 5
n/a n/a 5 Aug 28, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Underweight
8
19.27 -58.48% 7 Jun 11, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
26
n/a n/a 3 Jun 11, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
52
26.46 96.52% 2 Jun 11, 2019